Using Motivational Interviewing and Brief Action Planning to build commitment, improve adherence, and support long-term weight management.
GLP-1 medications have emerged as a possible pharmacological treatment for patients with non-alcoholic fatty liver disease.
Sleep loss increases the risk of unwanted weight gain and disruptions in hunger hormones
The health benefits conferred by GLP-1 medications can be quite literally life-changing and life-saving, so it is important to consider the ethics of prescribing these medications — especially as demand rises and shortages ebb and flow.
To help patients achieve weight loss success and improve clinical outcomes, health care providers must understand the factors that inform patient decisions regarding obesity treatment.
For patients exhibiting clinically clear signs of hyperphagia — such as chronic hunger, frequent snacking, and heightened food-cue reactivity — GLP-1 medications may offer significant relief. However, in addition to pharmacotherapy, a comprehensive treatment approach may be beneficial for these patients.
When patients stop taking semaglutide, health care providers should prepare them for possible withdrawal symptoms such as weight regain, increased appetite and food cravings, and the re-emergence of cardiovascular and metabolic risk factors. Semaglutide is an effective pharmacotherapy for helping…
Many people do not realize the importance of skin care, which, if overlooked, can lead to a variety of skin problems that are exacerbated by obesity. Skin is the largest organ of the body and it creates a protective barrier…
The health care environment has risen to overcome unprecedented obstacles over the past few years, but there are still challenges on the horizon. Every New Year brings the promise of opportunity. The health care environment has experienced unprecedented challenges over…
The pinpoint focus on COVID-19 has shifted attention from other critically important public health issues that continue to affect the population, including obesity. As another unimaginable year ends, COVID-19 remains in the spotlight, and with good reason. However, this pinpoint…